Valuation: CVRx, Inc.

Market Cap 149M 130M 119M 111M 211M 14.15B 214M 1.43B 557M 6.95B 558M 546M 23.97B P/E 2026 *
-2.85x
P/E 2027 * -2.96x
Enterprise Value 174M 152M 140M 130M 247M 16.58B 251M 1.68B 653M 8.14B 654M 639M 28.09B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.85x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week-4.44%
Current month+8.95%
1 month+3.90%
3 months-37.85%
6 months-21.13%
Current year-21.13%
1 week 5.02
Extreme 5.025
6.01
1 month 4.76
Extreme 4.76
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
05-31
Treo Ventures LLC
OtherCompany 0 0%
05-31Free

Director

19,902 0.0750%
05-31Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-4.44%-14.89%-63.64% 149M
+0.68%+0.61%+26.89%-5.96% 12.53B
+2.20%+3.73%+64.78%+37.36% 6.36B
+1.56%+5.29%+7.24%+11.92% 5.87B
+2.63%+9.48% - - 4.38B
-0.16%+7.39%-33.87%+6.45% 4.05B
+1.60%+3.99%-25.95%-26.03% 3.91B
+9.00%+11.47%-2.88%-59.39% 1.99B
+1.43%+4.40%+30.75%+241.52% 1.88B
+0.94%+0.54%+56.10%-7.11% 1.55B
Average +2.17%+4.83%+12.02%+15.01% 4.27B
Weighted average by Cap. +1.67%+3.60%+18.00%+12.34%

Financials

2026 *2027 *
Net sales 65.28M 57.1M 52.4M 48.92M 92.69M 6.22B 94.07M 630M 245M 3.05B 245M 240M 10.53B 76.18M 66.62M 61.15M 57.08M 108M 7.25B 110M 735M 286M 3.56B 286M 280M 12.29B
Net income -52.82M -46.2M -42.4M -39.58M -74.99M -5.03B -76.11M -509M -198M -2.47B -198M -194M -8.52B -52.14M -45.6M -41.85M -39.07M -74.03M -4.96B -75.13M -503M -195M -2.44B -196M -191M -8.41B
Net Debt 25.51M 22.31M 20.48M 19.12M 36.22M 2.43B 36.76M 246M 95.63M 1.19B 95.79M 93.7M 4.12B 68.44M 59.86M 54.93M 51.28M 97.17M 6.52B 98.61M 660M 257M 3.2B 257M 251M 11.04B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
02/07/26 US$5.600 +1.82% 149,552
01/07/26 US$5.500 +7.00% 332,198
30/06/26 US$5.140 -13.47% 414,999
29/06/26 US$5.940 +1.37% 343,571
26/06/26 US$5.860 +11.62% 791,353
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.600USD
Average target price
11.17USD
Spread / Average Target
+99.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock